Research
Hormonal
Men with low plasma adiponectin levels had a higher risk of colorectal cancer than men with higher levels.
Practitioners should consider monitoring plasma adiponectin levels as a potential risk factor for colorectal cancer.
GoodSupportsmedium confidence
In this prospective nested case-control study, men with low plasma adiponectin levels had a higher risk of colorectal cancer than men with higher levels.
Why this rating
The study is a prospective nested case-control study.
Source
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
Esther K. Wei et al. · JNCI Journal of the National Cancer Institute · 2005
DOI 10.1093/jnci/dji376
cohort · n=18225Cited 495×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →